Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04145193
Title Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRC
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors MedImmune LLC
Indications

colorectal cancer

Therapies

Durvalumab + Fluorouracil + Leucovorin + Oleclumab + Oxaliplatin

Durvalumab + Fluorouracil + Leucovorin + Oxaliplatin

Durvalumab + Fluorouracil + Leucovorin + Monalizumab + Oxaliplatin

Fluorouracil + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries


No variant requirements are available.